FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
208653NDAZEVRA THERAP001APADAZTABLET;ORAL325MG;EQ 6.12MG BASEACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE2018-02-23DiscontinuedNo
002APADAZTABLET;ORAL325MG;EQ 4.08MG BASEACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE2018-02-23DiscontinuedNo
003APADAZTABLET;ORAL325MG;EQ 8.16MG BASEACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE2018-02-23DiscontinuedNo